Onderneming Lansen Pharmaceutical Holdings Limited
Aandelen
503
KYG5380M1033
Farmaceutische producten
Vakgebied
Aantal werknemers: 652
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Li Chen
CEO | Chief Executive Officer | 62 | 01-03-18 |
Kai Fai Pang
SEC | Corporate Secretary | - | 13-06-19 |
Yu Zhao
HRO | Human Resources Officer | 51 | 11-12-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ching Har Chan
BRD | Director/Board Member | 67 | 10-02-22 |
Zhen Tao Wu
CHM | Chairman | 70 | 30-03-17 |
Kee Huen Chan
BRD | Director/Board Member | 72 | 09-04-10 |
Xun Zhu
BRD | Director/Board Member | 66 | 23-09-22 |
Xue Zi Liu
BRD | Director/Board Member | 47 | 30-03-16 |
Li Chen
CEO | Chief Executive Officer | 62 | 01-03-18 |
Tak Bun Yeung
BRD | Director/Board Member | 58 | 06-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 419 328 434 | 133 103 274 ( 31,74 %) | 0 | 31,74 % |
Bedrijfsgegevens
Lansen Pharmaceutical Holdings Ltd.
228 Xinfeng Road Gaoqiao Industrial Park
315174, Ningbo
+
http://www.lansen.com.cnSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |